Learn More
ATCC BT-20; Breast Carcinoma; Human (Homo sapiens)
Supplier: ATCC HTB19
BT-20 cells were isolated in 1958 from a breast tumor of a 74-year-old, White, female breast cancer patient. Use these cells in your breast cancer and immuno-oncology research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.